Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate

Journal of Veterinary Science

Volumn 12, Issue 4, 2011, Pages 401-403

  Shin, Min Kyoung ^a   Jung, Myung Hwan ^a   Lee, Won Jung ^a   Choi, Pil Son ^b   Jang, Yong Suk ^c   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b Nambu University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Actinobacillus pleuropneumoniae; ApxIIA; cholera toxin B subunit protein; Transgenic plant

Indexed keywords

APXII TOXIN, BACTERIA; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; CHOLERA TOXIN; HEMOLYSIN;

ACTINOBACILLUS INFECTION; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ARTICLE; CHEMISTRY; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MAIZE; MICROBIOLOGY; MOUSE; TRANSGENIC PLANT;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CHOLERA TOXIN; FEMALE; HEMOLYSIN PROTEINS; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED ICR; PLANTS, GENETICALLY MODIFIED; ZEA MAYS;

ACTINOBACILLUS PLEUROPNEUMONIAE; MUS; MYCOPLASMA; SUS; ZEA MAYS;

EID: 84860720976     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2011.12.4.401     Document Type: Article

References (13)

1. Arakawa T, Chong DKX, Merritt JL, Langridge WHR. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res 1997, 6, 403-413.
2. Bossé JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, Langford PR. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect 2002, 4, 225-235.
3. Floss DM, Falkenburg D, Conrad U. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res 2007, 16, 315-332.
4. Frey J, Nicolet J. Immunological properties of Actinobacillus pleuropneumoniae hemolysin I. Vet Microbiol 1991, 28, 61-73.
5. Kim HA, Yoo HS, Yang MS, Kwon SY, Kim JS, Choi PS. The development of transgenic maize expressing Actinobacillus pleuropneumoniae ApxIIA gene using Agrobacterium. J Plant Biotechnol 2010, 37, 313-318.
6. Kim JM, Jung DI, Eom YJ, Park SM, Yoo HS, Jang YS, Yang MS, Kim DH. Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae. Biosci Biotechnol Biochem 2010, 74, 1362-1367.
7. Lamphear BJ, Jilka JM, Kesl L, Welter M, Howard JA, Streatfield SJ. A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 2004, 22, 2420-2424.
8. Lee KY, Kim DH, Kang TJ, Kim J, Chung GH, Yoo HS, Arntzen CJ, Yang MS, Jang YS. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol Med Microbiol 2006, 48, 381-389.
9. Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 2002, 8, 324-329.
10. Sala F, Manuela Rigano M, Barbante A, Basso B, Walmsley AM, Castiglione S. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 2003, 21, 803-808.
11. Seo KW, Kim DH, Kim AH, Yoo HS, Lee KY, Jang YS. Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge. Immunol Invest 2011, 40, 465-480.
12. Shin SJ, Bae JL, Cho YW, Lee DY, Kim DH, Yang MS, Jang YS, Yoo HS. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. FEMS Immunol Med Microbiol 2005, 43, 155-164.
13. Sosroseno W, Barid I, Herminajeng E, Susilowati H. Nitric oxide production by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002, 17, 72-78.